# HS research update (2026-06-15): What’s new on PubMed?

Canonical URL: https://acneinversa.life/en/blog/hs-research-update-2026-06-15/
Markdown URL: https://acneinversa.life/en/blog/hs-research-update-2026-06-15.md
Plain text URL: https://acneinversa.life/en/blog/hs-research-update-2026-06-15.txt
Language: en
Category: Research
Published: 2026-06-15
Last updated: 2026-06-15
Author: Dr. rer. nat. Dennis Alexander Kwiatkowski (Biochemist, Scientific Writer and Pharma Expert)
Tags: Acne Inversa, Hidradenitis Suppurativa, HS, Research, hidradenitis suppurativa, acne inversa, research update, biologics, comorbidities, pain, quality of life, surgery, wound care

> A patient-friendly overview of new PubMed publications on hidradenitis suppurativa (acne inversa) — with sources, clear limitations, and no medical advice.

Medical disclaimer: This website is for general educational information only and does not replace medical advice, diagnosis, or treatment. Please speak with qualified medical professionals about symptoms or treatment decisions.

## Article

## Publication overview

This update includes **13 PubMed publications with abstracts** from the monitoring window **2026-06-01 to 2026-06-15**. The most common themes are **comorbidities, quality of life, surgery, pain, biologics**.

- Compared with the previous update: not automatically assessed.
- This is a research overview, not a guideline update or medical recommendation.

## Top highlights

The most useful signal this round is not a single treatment instruction. It is what researchers are looking at more closely: wound healing after procedures, possible new anti-inflammatory approaches, care quality, and comorbidities.

- **Rapid Remission through Multimodal Therapy in a Severe Form of PASH Syndrome: A Case Report.:** The abstract describes a new publication. In practical terms, it focuses on this question or finding: PASH syndrome is a rare autoinflammatory dermatosis characterized by the triad of pyoderma gangrenosum (PG), acne conglobata, and hidradenitis suppurativa (HS), driven by innate immune dysregulation and IL-1-mediated… What makes it notable here is that it approaches HS through **surgery, pain, biologics, wound care**. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. ([PMID 42256375](https://pubmed.ncbi.nlm.nih.gov/42256375/))
- **Palliative and Supportive Care Needs in Advanced Hidradenitis Suppurativa: A Systematic Review.:** The abstract describes a systematic review. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition associated with severe symptom burden, high psychiatric comorbidity, and profound impairment in health-related quality of life (HRQoL). Despite th… What makes it notable here is that it approaches HS through **comorbidities, pain, quality of life**. The main limitation to keep in mind is: Its strength depends on the quality and comparability of the included studies, and an abstract does not expose every methodological weakness. ([PMID 42272576](https://pubmed.ncbi.nlm.nih.gov/42272576/))
- **Informatics-Based Psychotherapeutic and Psychiatric Interventions in Dermatology: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes.:** The abstract describes a new publication. In practical terms, it focuses on this question or finding: Chronic dermatologic conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa are associated with a high burden of psychiatric comorbidities, including depression, anxiety, and suicidality. Despit… What makes it notable here is that it approaches HS through **comorbidities, quality of life**. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. ([PMID 42269173](https://pubmed.ncbi.nlm.nih.gov/42269173/))
- **Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches.:** The abstract describes a new publication. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disorder of the pilosebaceous unit, characterized by nodules, abscesses, and sinus tracts formation in apocrine gland-bearing skin. Increasing ev… What makes it notable here is that it approaches HS through **comorbidities, biologics**. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. ([PMID 42266681](https://pubmed.ncbi.nlm.nih.gov/42266681/))
- **The Impact of Hidradenitis Suppurativa on Sexual Function: A Multicentered Cross-Sectional Study.:** The abstract describes a multicenter study. In practical terms, it focuses on this question or finding: Hidradenitis suppurativa (HS) is a disease that impairs the quality of life (QoL), sexual functioning, and fertility of the patients. The relationship between disease characteristics and sexual function remains insuff… What makes it notable here is that it approaches HS through **pain, quality of life**. The main limitation to keep in mind is: From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full. ([PMID 42268671](https://pubmed.ncbi.nlm.nih.gov/42268671/))

## Featured publication

The featured paper is **IL-1-Targeted Therapy in Dermatologic Conditions.** in **Journal of the American Academy of Dermatology** ([PMID 42264383](https://pubmed.ncbi.nlm.nih.gov/42264383/)). The abstract mainly says this: Interleukin-1 (IL-1) plays a key role in inflammasome activation, keratinocyte signalling and neutrophil recruitment, and is a driving force behind many neutrophil-rich and suppurative dermatoses. There is robust evid…

Why it stands out: it connects to the priority themes **no automatic topic tag** and shows what HS researchers are trying to clarify right now. For readers, it matters because it gives one concrete example of how the field is framing a practical question or possible mechanism. The main limitation is that From the abstract alone, it is hard to judge the study design, patient selection, and follow-up in full.

## What this may mean for patients (carefully, no advice)

If you live with HS, research updates can help you make sense of what’s being studied — for example which outcomes (pain, quality of life) researchers measure, or which comorbidities are increasingly part of the conversation.

But even when a study sounds promising, it usually does not tell you what is right **for you personally**. Consider using new findings as questions for your next appointment (e.g., “What are realistic goals for me?” or “Which related conditions should we keep an eye on?”), not as instructions.

## What we don’t know / limitations

- This update includes **only** PubMed items with an abstract (without an abstract, safe summarization is limited).
- Studies vary widely (design, populations, outcome measures).
- This update provides **no** treatment advice and cannot assess individual risk.

## Important: decisions belong in clinician conversations

This article is an editorial overview and is **not medically reviewed**. If something here worries or interests you, use it as a conversation starter for your next appointment. Decisions should always be made with qualified healthcare professionals.

## FAQ

### Why are there only a few new publications here?
This format is deliberately strict: it includes only new PubMed items from the monitoring window that have an abstract and were not already covered in earlier posts.

### Does a new paper mean my treatment should change?
No. A single publication can be useful to know about, but it is usually not enough to guide decisions for one specific person.

### Why emphasize limitations so much?
Because abstracts show only part of the picture. Study design, patient population, endpoints, and follow-up all matter before results can be interpreted responsibly.

## Sources & original papers

Each point below maps to an original source (PubMed link, plus DOI/PMCID when available).

## References

1. New Frontiers of Skin Ultrasound in Precision Medicine. - Ultrasound in medicine & biology, 2026 — PMID 42285862 · DOI 10.1016/j.ultrasmedbio.2026.05.015 - https://pubmed.ncbi.nlm.nih.gov/42285862/
2. Informatics-Based Psychotherapeutic and Psychiatric Interventions in Dermatology: Scoping Review of Impacts on Skin Disease Severity and Mental Health Outcomes. - JMIR dermatology, 2026 — PMID 42269173 · DOI 10.2196/82096 · PMCID PMC13252885 - https://pubmed.ncbi.nlm.nih.gov/42269173/
3. Enhanced Diagnosis of Generalized Pustular Psoriasis With the Legit.Health Device as a Diagnosis Support Tool: Multireader Multicase Study. - JMIR dermatology, 2026 — PMID 42269023 · DOI 10.2196/82030 · PMCID PMC13252704 - https://pubmed.ncbi.nlm.nih.gov/42269023/
4. The Impact of Hidradenitis Suppurativa on Sexual Function: A Multicentered Cross-Sectional Study. - International journal of dermatology, 2026 — PMID 42268671 · DOI 10.1111/ijd.70522 - https://pubmed.ncbi.nlm.nih.gov/42268671/
5. IL-1-Targeted Therapy in Dermatologic Conditions. - Journal of the American Academy of Dermatology, 2026 — PMID 42264383 · DOI 10.1016/j.jaad.2026.06.021 - https://pubmed.ncbi.nlm.nih.gov/42264383/
6. Comparing the measurement properties, informativity and responsiveness of the DLQI, DLQI-Relevant (DLQI-R), and Skindex-29 in patients with chronic skin disease: a prospective cohort study. - Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026 — PMID 42260199 · DOI 10.1007/s11136-026-04286-w - https://pubmed.ncbi.nlm.nih.gov/42260199/
7. Thoracodorsal Artery Perforator Flap Versus Split-Thickness Skin Graft Reconstruction for Advanced Axillary Hidradenitis Suppurativa: Long-Term Outcomes. - Journal of clinical medicine, 2026 — PMID 42279256 · DOI 10.3390/jcm15114395 - https://pubmed.ncbi.nlm.nih.gov/42279256/
8. Redundant γc cytokines license IL-1-driven neutrophil inflammation through MEK/ERK convergence. - bioRxiv : the preprint server for biology, 2026 — PMID 42282585 · DOI 10.64898/2026.05.28.728506 · PMCID PMC13252156 - https://pubmed.ncbi.nlm.nih.gov/42282585/
9. Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches. - Frontiers in immunology, 2026 — PMID 42266681 · DOI 10.3389/fimmu.2026.1827227 · PMCID PMC13243088 - https://pubmed.ncbi.nlm.nih.gov/42266681/
10. Palliative and Supportive Care Needs in Advanced Hidradenitis Suppurativa: A Systematic Review. - Cureus, 2026 — PMID 42272576 · DOI 10.7759/cureus.108573 · PMCID PMC13247365 - https://pubmed.ncbi.nlm.nih.gov/42272576/
11. Staphylococcal proliferation on skin models to investigate novel anti-infective treatments against dysbiosis. - Bioengineering & translational medicine, 2026 — PMID 42272967 · DOI 10.1002/btm2.70124 · PMCID PMC13247412 - https://pubmed.ncbi.nlm.nih.gov/42272967/
12. [Climate change and skin]. - Revue medicale de Liege, 2026 — PMID 42257359 - https://pubmed.ncbi.nlm.nih.gov/42257359/
13. Rapid Remission through Multimodal Therapy in a Severe Form of PASH Syndrome: A Case Report. - Case reports in dermatology, 2026 — PMID 42256375 · DOI 10.1159/000551256 · PMCID PMC13241081 - https://pubmed.ncbi.nlm.nih.gov/42256375/